Paroxetine-induced severe sleep bruxism successfully treated with buspirone
نویسنده
چکیده
Sleep bruxism is characterized by the involuntary clenching or grinding of the teeth during sleep and can cause severe health problems, including the destruction of tooth structure, temporo-mandibular joint dysfunction, myofascial pain, and severe sleep disturbances (1). Iatrogenic sleep bruxism may be common during treatment with pyschotropic medications, such as antipsychotics and antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) (2). This article reports the case of a depressive woman with paroxetine-induced sleep bruxism who was successfully treated with buspirone.
منابع مشابه
Paroxetine induced bruxism, treated with Buspirone : An unexplored entity
SSRI are the widely prescribed first line drugs for depression and as depression very commonly presents with insomnia SSRI are good at improving the sleep problems also. But though rare the occurrence of sleep related side effects like bruxism,it may cause significant distress and cause of nonadherence which easily may be overlooked. In this case we report a case of Paroxetine induced bruxism a...
متن کاملAntidepressant-induced bruxism: need for buspirone?
Bruxism is an involuntary grinding of the teeth which can occur during daytime or night. An estimated 85–90% of the population brux at some time during their lives, but it is clinically significant in only 5% of them. In such cases it can result in significant periodontal damage and can produce significant sleep disturbance in the bed partner of the person (Moore et al., 2000). Reports of SSRI-...
متن کاملDystonias and Dyskinesias of the Jaw Associated with the Use of SSRIs
The 5HT reuptake inhibiting antidepressants (SSRIs) were introduced into clinical practice in the late 1980s. From the time of their introduction a series of reports have appeared indicating that they were liable to produce motor (extrapyramidal),sideeffects (Meltzer et al., 1979; Bouchard et al., 1989; Baldwin et al., 1991), including dystonias (Brod, 1989; Reccoppa et al., 1990), dyskinesias ...
متن کاملLow-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
OBJECTIVE Sleep disturbances are common among women in midlife; prevalence increases among perimenopausal/postmenopausal women with vasomotor symptoms. Paroxetine 7.5 mg is the only nonhormonal treatment that has been approved in the United States for moderate to severe vasomotor symptoms associated with menopause. In two pivotal phase 3 studies evaluating its efficacy and safety, improvements ...
متن کاملExtra-Paramidal Side Effects Associated with Paroxetine
A 29-year-old man admitted to a psychiatric unit was successfully treated for a paranoid psychosis with trifluoperazine. Following reduction of neuroleptic dosage and addition of paroxetine he developed severe extra-pyramidal side effects. These remitted after withdrawal of medication and did not recur following recommencement of trifluoperazine. This is the first report of such a side effect a...
متن کامل